ES2570463T3 - Sulfonamidas para la prevención de la diabetes - Google Patents
Sulfonamidas para la prevención de la diabetesInfo
- Publication number
- ES2570463T3 ES2570463T3 ES10768898T ES10768898T ES2570463T3 ES 2570463 T3 ES2570463 T3 ES 2570463T3 ES 10768898 T ES10768898 T ES 10768898T ES 10768898 T ES10768898 T ES 10768898T ES 2570463 T3 ES2570463 T3 ES 2570463T3
- Authority
- ES
- Spain
- Prior art keywords
- sulfonamides
- diabetes prevention
- diabetes
- prevention
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 229940124530 sulfonamide Drugs 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09172365A EP2308485A1 (en) | 2009-10-06 | 2009-10-06 | Sulfonamides for the prevention of diabetes |
| PCT/EP2010/064920 WO2011042465A1 (en) | 2009-10-06 | 2010-10-06 | Sulfonamides for the prevention of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2570463T3 true ES2570463T3 (es) | 2016-05-18 |
Family
ID=41716341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10768898T Active ES2570463T3 (es) | 2009-10-06 | 2010-10-06 | Sulfonamidas para la prevención de la diabetes |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US8846755B2 (enExample) |
| EP (2) | EP2308485A1 (enExample) |
| JP (1) | JP5745526B2 (enExample) |
| KR (1) | KR101737656B1 (enExample) |
| CN (1) | CN102639128B (enExample) |
| AU (1) | AU2010305384B2 (enExample) |
| BR (1) | BR112012007989B1 (enExample) |
| CA (1) | CA2776021C (enExample) |
| CY (1) | CY1117599T1 (enExample) |
| DK (1) | DK2485724T3 (enExample) |
| EA (1) | EA021788B1 (enExample) |
| ES (1) | ES2570463T3 (enExample) |
| HR (1) | HRP20160399T1 (enExample) |
| HU (1) | HUE028132T2 (enExample) |
| IL (1) | IL219038A (enExample) |
| ME (1) | ME02385B (enExample) |
| MX (1) | MX2012004087A (enExample) |
| NZ (1) | NZ599171A (enExample) |
| PL (1) | PL2485724T3 (enExample) |
| RS (1) | RS54693B1 (enExample) |
| SI (1) | SI2485724T1 (enExample) |
| SM (1) | SMT201600126B (enExample) |
| WO (1) | WO2011042465A1 (enExample) |
| ZA (1) | ZA201202462B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| EP2308485A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
| EP3281937A1 (en) * | 2016-08-09 | 2018-02-14 | Dompé farmaceutici S.p.A. | Sulfonamides as gpr40- and gpr120-agonists |
| WO2018067548A1 (en) | 2016-10-03 | 2018-04-12 | The Children's Medicial Center Corporation | Prevention and treatment of diabetic nephropathy |
| EP4686469A1 (en) | 2024-07-31 | 2026-02-04 | Dompé farmaceutici SpA | Cxcl8 inhibitors for use in the treatment of diabetes-associated comorbidities |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1303249B1 (it) | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| ITMI20010206A1 (it) * | 2001-02-02 | 2002-08-02 | Dompe Spa | Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz |
| US20040242498A1 (en) * | 2003-02-27 | 2004-12-02 | Collins Tassie L. | CXCR3 antagonists |
| HRP20090681T1 (hr) | 2004-03-23 | 2010-02-28 | Dompe' S.P.A. | Derivati 2-fenilpropionske kiseline i farmaceutski pripravci koji ih sadrže |
| DE602004003673T2 (de) | 2004-03-25 | 2007-10-04 | Dompe' Pha.R.Ma S.P.A. | Verwendung von N-(2-Aryl-propionyl)-sulfonamiden zur Behandlung von Rückenmarkverletzungen |
| KR20110014141A (ko) * | 2008-03-20 | 2011-02-10 | 카롤러스 테라퓨틱스, 인코포레이티드 | 염증을 치료하는 방법 |
| EP2308484A1 (en) * | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| EP2308485A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
-
2009
- 2009-10-06 EP EP09172365A patent/EP2308485A1/en not_active Withdrawn
-
2010
- 2010-10-06 ME MEP-2016-71A patent/ME02385B/me unknown
- 2010-10-06 AU AU2010305384A patent/AU2010305384B2/en active Active
- 2010-10-06 DK DK10768898.8T patent/DK2485724T3/en active
- 2010-10-06 HU HUE10768898A patent/HUE028132T2/en unknown
- 2010-10-06 CN CN201080044851.6A patent/CN102639128B/zh active Active
- 2010-10-06 WO PCT/EP2010/064920 patent/WO2011042465A1/en not_active Ceased
- 2010-10-06 JP JP2012532578A patent/JP5745526B2/ja active Active
- 2010-10-06 CA CA2776021A patent/CA2776021C/en active Active
- 2010-10-06 ES ES10768898T patent/ES2570463T3/es active Active
- 2010-10-06 EP EP10768898.8A patent/EP2485724B1/en active Active
- 2010-10-06 MX MX2012004087A patent/MX2012004087A/es active IP Right Grant
- 2010-10-06 BR BR112012007989A patent/BR112012007989B1/pt active IP Right Grant
- 2010-10-06 SI SI201031165T patent/SI2485724T1/sl unknown
- 2010-10-06 EA EA201270512A patent/EA021788B1/ru unknown
- 2010-10-06 NZ NZ599171A patent/NZ599171A/en unknown
- 2010-10-06 KR KR1020127010733A patent/KR101737656B1/ko active Active
- 2010-10-06 PL PL10768898T patent/PL2485724T3/pl unknown
- 2010-10-06 RS RS20160230A patent/RS54693B1/sr unknown
- 2010-10-06 HR HRP20160399TT patent/HRP20160399T1/hr unknown
- 2010-10-06 US US13/500,522 patent/US8846755B2/en active Active
-
2012
- 2012-04-04 IL IL219038A patent/IL219038A/en active IP Right Grant
- 2012-04-04 ZA ZA2012/02462A patent/ZA201202462B/en unknown
-
2014
- 2014-09-26 US US14/497,637 patent/US9556115B2/en active Active
-
2016
- 2016-05-03 SM SM201600126T patent/SMT201600126B/it unknown
- 2016-05-06 CY CY20161100375T patent/CY1117599T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY32490A (es) | Inhibidores de beta-secretasa | |
| EA201270216A1 (ru) | Фармацевтический состав | |
| CL2008003690A1 (es) | Compuestos derivados de amonobenzamida; composicion farmceutica que comprende los compuestos; y uso para controlar parasitos. | |
| ECSP11011411A (es) | Derivados de prolina como inhibidores de catepsina | |
| ECSP12011799A (es) | Compuestos de espiropiperidina y uso farmacéutico de los mismos | |
| SV2010003472A (es) | Compuestos de pirazol | |
| EA201200049A1 (ru) | 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17 | |
| CR11518A (es) | Compuestos de carbamoilo como inhibidores de dgat1 190 | |
| CO6620055A2 (es) | Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos | |
| NO20091395L (no) | Nye tiofenderivater | |
| SV2008003088A (es) | Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen | |
| NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
| CR20110370A (es) | Derivados de sulfonamida | |
| CL2011000242A1 (es) | Uso de compuestos derivados de fenilaminopirimidina para tratar talasemia alfa, delta y anemia celular falciforme, talasemia mayor, talasemia menor, talasemia e-beta o talasemia beta falciforme, o para mejorar o retrasar los sintomas de las mismas y uso de un compuesto especifico para tratar la talasemia. | |
| BR112015007310A2 (pt) | compostos, composição farmacêutica, uso de um composto de fórmula (i) e uso de uma composição farmacêutica | |
| DOP2012000006A (es) | Agonista de gpr119 | |
| SV2009002865A (es) | Uso de oxazolidinonas para el tratamiento y profilaxis de microangiopatias | |
| CL2012002716A1 (es) | Uso de un compuesto inhibidores de dgat1 porque es útil en la prevención, demora del progreso o el tratamiento de una enfermedad o condición seleccionada a partir de quilomicronemia, síndrome de quilomicronemia familiar e hiperlipoproteinemia tipo v; un compuesto derivado de heteroarilo sustituido; composición farmacéutica. | |
| AR083417A1 (es) | Composiciones farmaceuticas que contienen un dgat1 inhibidor | |
| BRPI0916480A2 (pt) | composto de fórmula geral (i) e uso de pelo menos um composto | |
| BRPI0924882A2 (pt) | Composição para cuidado oral, e, uso de pelo menos um composto de carbonato e pelo menos um excipiente | |
| EA201290229A1 (ru) | Производные спиролактама и их применение | |
| AR090806A1 (es) | Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii | |
| UY32408A (es) | Macrolido anti-inflamatorio | |
| AR079170A1 (es) | Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio par |